Stay updated on Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page
- Check3 days agoChange DetectedFooter updates include Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link; the rest of the page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a note clarifying that publications are provided voluntarily and updated the revision to v3.3.2. Removed the previous note about publications relating to the study results, which referred to revision v3.2.0.SummaryDifference0.1%

- Check39 days agoChange Detected- The site-wide notice about government funding status and NIH operations was removed from the page.SummaryDifference0.4%

- Check53 days agoChange DetectedPublication of KEYNOTE-122 results is now listed with the citation, and study record dates plus IPD sharing information have been updated. The page references the 2023 Ann Oncol publication and related data-sharing documentation.SummaryDifference0.4%

- Check82 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference2%

- Check89 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.